| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Revenue | $785.0M | +2.8% |
| Cost of Revenue | $476.1M | +4.5% |
| Gross Profit | $308.9M | +0.3% |
| R&D Expense | $115.7M | -5.1% |
| SG&A Expense | $133.1M | -6.1% |
| Operating Income | $57.1M | -11.9% |
| Interest Expense | $521K | +24.6% |
| Pre-tax Income | $69.4M | -12.6% |
| Income Tax | $13.0M |
| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $103.3M | -45.8% |
| Accounts Receivable | $125.4M | +20.3% |
| Inventory | $110.9M | +9.1% |
| Current Assets | $557.1M | -7.9% |
| Total Assets | $1.22B | +6.8% |
| Current Liabilities | $123.9M | -5.7% |
| Long-term Debt | $12.2M | -8.3% |
| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $115.4M | -1.8% |
| Capital Expenditures | $103.7M | +169.7% |
| Investing Cash Flow | -$191.5M | -471.9% |
| Financing Cash Flow | -$13.6M | +78.9% |
| Free Cash Flow | $11.7M | -85.2% |
| +32.7% |
| Net Income | $54.4M | -21.9% |
| EPS (Basic) | $0.70 | -22.2% |
| EPS (Diluted) | $0.69 | -22.5% |
| Total Liabilities |
| $189.0M |
| -4.8% |
| Stockholders' Equity | $1.04B | +9.2% |